New Results
Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics
View ORCID ProfileDaniel R. Wong, Jay Conrad, Noah Johnson, View ORCID ProfileJacob I. Ayers, Annelies Laeremans, Joanne C. Lee, Jisoo Lee, View ORCID ProfileStanley B. Prusiner, View ORCID ProfileSourav Bandyopadhyay, View ORCID ProfileAtul J. Butte, View ORCID ProfileNick A. Paras, View ORCID ProfileMichael J. Keiser
doi: https://doi.org/10.1101/2021.01.08.425973
Daniel R. Wong
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
2Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, 94158, USA
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA
4Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA
5Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA
6Department of Pediatrics, University of California, San Francisco, CA, 94158, USA
7Center for Data-Driven Insights and Innovation, University of California, Office of the President, Oakland, CA, 94607, USA
Jay Conrad
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Noah Johnson
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Jacob I. Ayers
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Annelies Laeremans
4Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA
8Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA
Joanne C. Lee
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Jisoo Lee
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Stanley B. Prusiner
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Sourav Bandyopadhyay
4Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA
8Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA
Atul J. Butte
2Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, 94158, USA
6Department of Pediatrics, University of California, San Francisco, CA, 94158, USA
7Center for Data-Driven Insights and Innovation, University of California, Office of the President, Oakland, CA, 94607, USA
Nick A. Paras
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
Michael J. Keiser
1Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94158, USA
2Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, 94158, USA
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA
4Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA
5Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA
Article usage
Posted January 09, 2021.
Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics
Daniel R. Wong, Jay Conrad, Noah Johnson, Jacob I. Ayers, Annelies Laeremans, Joanne C. Lee, Jisoo Lee, Stanley B. Prusiner, Sourav Bandyopadhyay, Atul J. Butte, Nick A. Paras, Michael J. Keiser
bioRxiv 2021.01.08.425973; doi: https://doi.org/10.1101/2021.01.08.425973
Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics
Daniel R. Wong, Jay Conrad, Noah Johnson, Jacob I. Ayers, Annelies Laeremans, Joanne C. Lee, Jisoo Lee, Stanley B. Prusiner, Sourav Bandyopadhyay, Atul J. Butte, Nick A. Paras, Michael J. Keiser
bioRxiv 2021.01.08.425973; doi: https://doi.org/10.1101/2021.01.08.425973
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)